Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
For subcutaneous administration, patients self-inject once daily using a fine insulin-type needle
All methods were carried out in accordance with relevant guidelines and regulation
it was studied by Novo Nordisk and later Helsinn Therapeutics, including a Phase II trial for postoperative ileus, but development was discontinued for lack of efficacy
Results vary by dose, route, baseline pigmentation, and cofactors like vitamin C
Krajcovicov-Kudlckov, M., Blazcek, P., Kopcov, J., Bderov, A., & Babinsk, K
US$ 25.86
US$ 26.56
US$ 27.33
US$ 23.87
